Grading of age-related macular degeneration: Comparison between color fundus photography, fluorescein angiography, and spectral domain optical coherence tomography

Journal of Ophthalmology

Volumn 2013, Issue , 2013, Pages

  Mokwa, Nils F ^a   Ristau, Tina ^a   Keane, Pearse A ^b   Kirchhof, Bernd ^a   Sadda, Srinivas R ^c   Liakopoulos, Sandra ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878691651     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2013/385915     Document Type: Article

References (21)

1. Bressler N. M., Age-related macular degeneration is the leading cause of blindness. Journal of the American Medical Association 2004 291 15 1900 1901 2-s2.0-1942542429 10.1001/jama.291.15.1900 (Pubitemid 38509505)
2. Bird A. C., Bressler N. M., Bressler S. B., Chisholm I. H., Coscas G., Davis M. D., De Jong P. T. V. M., Klaver C. C. W., Klein B. E. K., Klein R., Mitchell P., Sarks J. P., Sarks S. H., Soubrane G., Taylor H. R., Vingerling J. R., An international classification and grading system for age-related maculopathy and age-related macular degeneration: the International ARM Epidemiological Study group. Survey of Ophthalmology 1995 39 5 367 374 2-s2.0-0028934221 10.1016/S0039-6257(05)80092-X
3. Age-Related Eye Disease Study Research Group, The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. American Journal of Ophthalmology 2001 132 5 668 681
4. Seddon J. M., Sharma S., Adelman R. A., Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 2006 113 2 260 266 2-s2.0-31644433343 10.1016/j.ophtha.2005.11.001 (Pubitemid 43170775)
5. Rosenfeld P. J., Brown D. M., Heier J. S., Boyer D. S., Kaiser P. K., Chung C. Y., Kim R. Y., Ranibizumab for neovascular age-related macular degeneration. The New England Journal of Medicine 2006 355 14 1419 1431 2-s2.0-33749445317 10.1056/NEJMoa054481 (Pubitemid 44511557)
6. Brown D. M., Kaiser P. K., Michels M., Soubrane G., Heier J. S., Kim R. Y., Sy J. P., Schneider S., Ranibizumab versus verteporfin for neovascular age-related macular degeneration. The New England Journal of Medicine 2006 355 14 1432 1444 2-s2.0-33749451356 10.1056/NEJMoa062655 (Pubitemid 44511558)
7. Kaiser P. K., Blodi B. A., Shapiro H., Acharya N. R., Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007 114 10 1868 e4 2-s2.0-34748844162 10.1016/j.ophtha.2007.04.030 (Pubitemid 47483925)
8. Fung A. E., Lalwani G. A., Rosenfeld P. J., Dubovy S. R., Michels S., Feuer W. J., Puliafito C. A., Davis J. L., Flynn H. W., Esquiabro M., An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. American Journal of Ophthalmology 2007 143 4 566 583 2-s2.0-33947403618 10.1016/j.ajo.2007.01.028 (Pubitemid 46452533)
9. Martin D. F., Maguire M. G., Ying G. S., Grunwald J. E., Fine S. L., Jaffe G. J., Ranibizumab and bevacizumab for neovascular age-related macular degeneration. CATT Research Group. The New England Journal of Medicine 2011 364 20 1897 1908
10. Keane P. A., Bhatti R. A., Brubaker J. W., Liakopoulos S., Sadda S. R., Walsh A. C., Comparison of clinically relevant findings from high-speed fourier-domain and conventional time-domain optical coherence tomography. American Journal of Ophthalmology 2009 148 2 242 248 2-s2.0-67650432142 10.1016/j.ajo.2009.03.004
11. Barbazetto I., Burdan A., Bressler N. M., Bressler S. B., Haynes L., Kapetanios A. D., Lukas J., Olsen K., Potter M., Reaves A., Rosenfeld P., Schachat A. P., Strong H. A., Wenkstern A., Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment-TAP and VIP report no. 2. Archives of Ophthalmology 2003 121 9 1253 1268 2-s2.0-17444449992 10.1001/archopht.121.9. 1253 (Pubitemid 37128403)
12. Hawkins B. S., Fine S. L., Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Archives of Ophthalmology 1993 111 9 1200 1209 2-s2.0-0027237206 (Pubitemid 23268780)
13. Keane P. A., Patel P. J., Liakopoulos S., Heussen F. M., Sadda S. R., Tufail A., Evaluation of age-related macular degeneration with optical coherence tomography. Survey of Ophthalmology 2012 57 5 389 414
14. Jain N., Farsiu S., Khanifar A. A., Bearelly S., Smith R. T., Izatt J. A., Toth C. A., Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs. Investigative Ophthalmology and Visual Science 2010 51 10 4875 4883 2-s2.0-77958121933 10.1167/iovs.09-4962
15. Do D. V., Gower E. W., Cassard S. D., Boyer D., Bressler N. M., Bressler S. B., Heier J. S., Jefferys J. L., Singerman L. J., Solomon S. D., Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC study. Ophthalmology 2012 119 4 771 778
16. Grossniklaus H. E., Gass J. D. M., Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. American Journal of Ophthalmology 1998 126 1 59 69 2-s2.0-0344541763 10.1016/S0002-9394(98)00145-7 (Pubitemid 28341219)
17. Khurana R. N., Dupas B., Bressler N. M., Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization. Ophthalmology 2010 117 7 1376 1380 2-s2.0-77954349362 10.1016/j.ophtha.2009.11.039
18. Eter N., Spaide R. F., Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy. Retina 2005 25 6 691 696 2-s2.0-24344458089 10.1097/00006982-200509000-00002 (Pubitemid 41254537)
19. Kozak I., Morrison V. L., Clark T. M., Bartsch D. U., Ro Lee B., Falkenstein I., Tammewar A. M., Mojana F., Freeman W. R., Discrepancy between fluorescein angiography and optical coherence tomography in detection of macular disease. Retina 2008 28 4 538 544 2-s2.0-42549106833 10.1097/IAE. 0b013e318167270b (Pubitemid 351589561)
20. Zweifel S. A., Engelbert M., Laud K., Margolis R., Spaide R. F., Freund K. B., Outer retinal tubulation a novel optical coherence tomography finding. Archives of Ophthalmology 2009 127 12 1596 1602 2-s2.0-73349109509 10.1001/archophthalmol.2009.326
21. Giani A., Luiselli C., Esmaili D. D., Salvetti P., Cigada M., Miller J. W., Staurenghi G., Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization. Investigative Ophthalmology & Visual Science 2011 52 8 5579 5586 10.1167/iovs.10-6617